PharmaShots | Incisive News in 3 Shots

Subscribe Now

LIB Therapeutics

LIB Therapeutics Signs an Agreement with Hasten Biopharmaceutical to Develop and Commercialize Lerodalcibep in Greater China

LIB Therapeutics Signs an Agreement with Hasten Biopharmaceutical to Develop and Commercialize Lerodalcibep in Greater China

September 13, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us